Catalio Capital Management, LP
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1958125
NEW YORK, NY
Position in SUPN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,205,762
-$9,590,248 QoQ
Shares Held
62,019
-75.9% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Catalio Capital Management, LP holds $3,205,762 across 1 Drug Manufacturers - Specialty & Generic name. SUPN ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
62,019 | $3,205,762 |
All Filings in SUPN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,205,762 | 62,019 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $12,796,010 | 257,465 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,720,031 | 287,090 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||